Draft Genome Sequences of 27 Salmonella enterica Serovar Schwarzengrund Isolates from Clinical Sources

Bijay K Khajanchi; Noah C Yoskowitz; Jing Han; Xiong Wang; Steven L Foley

doi:10.1128/MRA.01687-18

Draft Genome Sequences of 27 Salmonella enterica Serovar Schwarzengrund Isolates from Clinical Sources

Microbiol Resour Announc. 2019 Mar 21;8(12):e01687-18. doi: 10.1128/MRA.01687-18.

Authors

Bijay K Khajanchi¹, Noah C Yoskowitz^{2

3}, Jing Han², Xiong Wang⁴, Steven L Foley²

Affiliations

¹ National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA bijay.khajanchi@fda.hhs.gov.
² National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA.
³ Pennsylvania State University, University Park, Pennsylvania, USA.
⁴ Minnesota Department of Health, Saint Paul, Minnesota, USA.

Abstract

Twenty-seven Salmonella enterica serovar Schwarzengrund isolates from clinical sources were sequenced as part of a larger study to examine phenotypic and genotypic characteristics. The majority of the sequenced strains were isolated from human stool (n = 20) followed by urine (n = 3) and blood (n = 2). Four isolate sequences contained plasmids of known incompatibility groups.